≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Diabetes, insuline treatment (Kela reimbursement)

MESH PheWeb

KELA_DIAB_INSUL

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

KELA reimbursements: KELA codes 103

48980

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

48980

diagram downward connector

Check minimum number of events None

48980

diagram downward connector

Include endpoints None

48980

diagram downward connector
KELA_DIAB_INSUL

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 48980 21255 27725
Unadjusted prevalence (%) 13.77 10.71 17.62
Mean age at first event (years) 54.73 53.46 55.70

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.62 [2.38, 2.88] 2.4e-86 8060
15 years 0.01 1.76 [1.62, 1.92] 2.6e-39 4034
5 years 0.00 2.58 [2.38, 2.79] <1e-100 1965
1 year 0.00 3.67 [3.24, 4.17] 1.3e-91 528

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: KELA_DIAB_INSUL – Diabetes, insuline treatment (Kela reimbursement)
GWS hits:

Survival analyses between endpoints

↥

Plot

before Diabetes, insuline treatment (Kela reimbursement)
after Diabetes, insuline treatment (Kela reimbursement)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Diabetes, insuline treatment (Kela reimbursement)

↥